LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...

Gavi’s purchase puts the total number of vaccines pledged for Africa’s mpox response at more than 4.1 million. European ...

Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe ...

The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

Lessons learned from the Covid pandemic have left the world in a much better position to tackle the current mpox epidemic ...

At a briefing, Jean Kaseya, MD, MPH, Africa CDC's director-general, said Rwanda's mpox vaccine campaign began 2 days ago, and ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...

Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as ...